These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 37446383)

  • 1. A global neuronopathic gaucher disease registry (GARDIAN): a patient-led initiative.
    Collin-Histed T; Stoodley M; Beusterien K; Elstein D; Jaffe DH; Revel-Vilk S; Davies EH;
    Orphanet J Rare Dis; 2023 Jul; 18(1):195. PubMed ID: 37480076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revisiting the diagnosis of Gaucher disease in a family with multiple GBA1 variants.
    Ryan E; Tayebi N; D'Souza A; Lopez G; Lichtenberg J; Sidransky E
    Am J Med Genet A; 2023 Oct; 191(10):2647-2650. PubMed ID: 37449546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid home therapy infusion of velaglucerase alfa in naïve patients with Gaucher disease.
    Becker-Cohen M; Revel-Vilk S; Frydman D; Dinur T; Tiomkin M; Istaiti M; Arbel N; Bauer P; Cozma C; Rolfs A; Szer J; Zimran A
    Intern Med J; 2024 Mar; 54(3):398-403. PubMed ID: 37493453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of β-GC trafficking improves the lysosome function in Gaucher disease.
    Patel S; Radhakrishnan D; Kumari D; Bhansali P; Setty SRG
    Traffic; 2023 Oct; 24(10):489-503. PubMed ID: 37491971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for lysosomal diseases in a selected pediatric population: the case of Gaucher disease and acid sphingomyelinase deficiency.
    Di Rocco M; Vici CD; Burlina A; Venturelli F; Fiumara A; Fecarotta S; Donati MA; Spada M; Concolino D; Pession A
    Orphanet J Rare Dis; 2023 Jul; 18(1):197. PubMed ID: 37480063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein non-metastatic protein B (GPNMB) plasma values in patients with chronic visceral acid sphingomyelinase deficiency.
    Eskes ECB; van der Lienden MJC; Sjouke B; van Vliet L; Brands MMMG; Hollak CEM; Aerts JMFG
    Mol Genet Metab; 2023 Aug; 139(4):107631. PubMed ID: 37453187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Burden of Gaucher Disease at a Tertiary Care Public Hospital in Mumbai.
    Mhatre SP; Muranjan M; Gogtay NJ
    Indian J Pediatr; 2024 May; 91(5):463-469. PubMed ID: 37486590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First Three Years' Experience of Mucopolysaccharidosis Type-I Newborn Screening in California.
    Fillman T; Matteson J; Tang H; Mathur D; Zahedi R; Sen I; Bishop T; Neogi P; Feuchtbaum L; Olney RS; Sciortino S
    J Pediatr; 2023 Dec; 263():113644. PubMed ID: 37516270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and Management of Late-Onset Pompe Disease].
    Hahn P; Siefen RG; Benz K; Jackowski J; Köhler C; Lücke T
    Fortschr Neurol Psychiatr; 2024 Jan; 92(1-02):33-40. PubMed ID: 37494148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction to: Olipudase Alfa in Non-CNS Manifestations of Acid Sphingomyelinase Deficiency: A Profile of Its Use.
    Syed YY
    Clin Drug Investig; 2023 Aug; 43(8):667. PubMed ID: 37493879
    [No Abstract]   [Full Text] [Related]  

  • 11. Motor outcomes in patients with infantile and juvenile Pompe disease: Lessons from neurophysiological findings.
    Brassier A; Pichard S; Schiff M; Bouchereau J; Bérat CM; Caillaud C; Pion A; Khraiche D; Fauroux B; Oualha M; Barnerias C; Desguerre I; Hully M; Maquet M; Deladrière E; de Lonlay P; Gitiaux C
    Mol Genet Metab; 2023 Aug; 139(4):107650. PubMed ID: 37454519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Role of Phospholipase D in Bone Metabolism.
    Kim HJ; Lee DK; Choi JY
    J Bone Metab; 2023 May; 30(2):117-125. PubMed ID: 37449345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gaucher disease-associated alterations in mesenchymal stem cells reduce osteogenesis and favour adipogenesis processes with concomitant increased osteoclastogenesis.
    Crivaro A; Bondar C; Mucci JM; Ormazabal M; Feldman RA; Delpino MV; Rozenfeld PA
    Mol Genet Metab; 2020 Aug; 130(4):274-282. PubMed ID: 32536424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncoupling of osteoblast-osteoclast regulation in a chemical murine model of Gaucher disease.
    Mucci JM; Suqueli García F; de Francesco PN; Ceci R; Di Genaro S; Fossati CA; Delpino MV; Rozenfeld PA
    Gene; 2013 Dec; 532(2):186-91. PubMed ID: 24076352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal functions and dysfunctions: Molecular and cellular mechanisms underlying Gaucher disease and its association with Parkinson disease.
    Horowitz M; Braunstein H; Zimran A; Revel-Vilk S; Goker-Alpan O
    Adv Drug Deliv Rev; 2022 Aug; 187():114402. PubMed ID: 35764179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Pathophysiologic Cascade Leading to Osteoclastogenic Activation in Gaucher Disease Monocytes Generated via CRISPR/Cas9 Technology.
    Ormazabal ME; Pavan E; Vaena E; Ferino D; Biasizzo J; Mucci JM; Serra F; Cifù A; Scarpa M; Rozenfeld PA; Dardis AE
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/Cas9 Editing for Gaucher Disease Modelling.
    Pavan E; Ormazabal M; Peruzzo P; Vaena E; Rozenfeld P; Dardis A
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32380730
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.